Same Indication

Osimertinib vs Relebactam Anhydrous

Osimertinib vs Relebactam Anhydrous: Overview

This comparison examines the pharmacological differences between Osimertinib and Relebactam Anhydrous.

Mechanism of Action

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Osimertinib β€” 48 hours.

Chemical Properties

Molecular Formula: Osimertinib β€” C28H33N7O2.

Molecular Weight: Osimertinib β€” 499.6050 g/mol.

Type: Osimertinib β€” Small molecule; Relebactam Anhydrous β€” Small molecule.